Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo

I R Garrett, B F Boyce, R O Oreffo, L Bonewald, J Poser, G R Mundy, I R Garrett, B F Boyce, R O Oreffo, L Bonewald, J Poser, G R Mundy

Abstract

The mechanisms by which bone resorbing osteoclasts form and are activated by hormones are poorly understood. We show here that the generation of oxygen-derived free radicals in cultured bone is associated with the formation of new osteoclasts and enhanced bone resorption, identical to the effects seen when bones are treated with hormones such as parathyroid hormone (PTH) and interleukin 1 (IL-1). When free oxygen radicals were generated adjacent to bone surfaces in vivo, osteoclasts were also formed. PTH and IL-1-stimulated bone resorption was inhibited by both natural and recombinant superoxide dismutase, an enzyme that depletes tissues of superoxide anions. We used the marker nitroblue tetrazolium (NBT) to identify the cells that were responsible for free radical production in resorbing bones. NBT staining was detected only in osteoclasts in cultures of resorbing bones. NBT staining in osteoclasts was decreased in bones coincubated with calcitonin, an inhibitor of bone resorption. We also found that isolated avian osteoclasts stained positively for NBT. NBT staining in isolated osteoclasts was increased when the cells were incubated with bone particles, to which they attach. We confirmed the formation of superoxide anion in isolated avian osteoclasts using ferricytochrome c reduction as a method of detection. The reduction of ferricytochrome c in isolated osteoclasts was inhibited by superoxide dismutase. Our results suggest that oxygen-derived free radicals, and particularly the superoxide anion, are intermediaries in the formation and activation of osteoclasts.

References

    1. Endocrinology. 1968 Jan;82(1):149-56
    1. J Clin Invest. 1965 Jan;44:103-16
    1. J Biol Chem. 1970 Aug 25;245(16):4053-7
    1. J Invest Dermatol. 1980 May;74(5):285-8
    1. J Exp Med. 1980 Dec 1;152(6):1596-609
    1. Lab Invest. 1982 Jul;47(1):5-18
    1. J Clin Endocrinol Metab. 1982 Nov;55(5):956-60
    1. Anat Embryol (Berl). 1981;162(4):379-92
    1. Anat Embryol (Berl). 1982 Dec;165(3):405-13
    1. J Immunol. 1983 Jun;130(6):2763-6
    1. J Clin Invest. 1984 Mar;73(3):599-601
    1. Blood. 1984 Nov;64(5):959-66
    1. J Immunol Methods. 1985 Sep 3;82(1):161-7
    1. J Immunol. 1986 Apr 1;136(7):2478-82
    1. J Immunol. 1986 Aug 15;137(4):1312-8
    1. J Clin Invest. 1986 Oct;78(4):894-8
    1. J Clin Invest. 1987 Feb;79(2):319-26
    1. J Immunol. 1987 Feb 1;138(3):775-9
    1. Boll Soc Ital Biol Sper. 1986 Oct 30;62(10):1311-4
    1. J Clin Invest. 1988 Mar;81(3):932-8
    1. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5235-9
    1. J Biol Chem. 1968 Nov 10;243(21):5753-60

Source: PubMed

3
Prenumerera